PT1904854E - Processo para a identificação de inibidores da dobragem de proteínas - Google Patents

Processo para a identificação de inibidores da dobragem de proteínas Download PDF

Info

Publication number
PT1904854E
PT1904854E PT06762655T PT06762655T PT1904854E PT 1904854 E PT1904854 E PT 1904854E PT 06762655 T PT06762655 T PT 06762655T PT 06762655 T PT06762655 T PT 06762655T PT 1904854 E PT1904854 E PT 1904854E
Authority
PT
Portugal
Prior art keywords
identification
inhibitors
proteins
folding inhibitors
proteins folding
Prior art date
Application number
PT06762655T
Other languages
English (en)
Inventor
Ricardo Broglia
Guido Tiana
Original Assignee
Univ Degli Studi Milano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Milano filed Critical Univ Degli Studi Milano
Publication of PT1904854E publication Critical patent/PT1904854E/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • AIDS & HIV (AREA)
  • Neurology (AREA)
PT06762655T 2005-07-19 2006-07-17 Processo para a identificação de inibidores da dobragem de proteínas PT1904854E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20050015597 EP1746422A1 (en) 2005-07-19 2005-07-19 Method for the identification of proteins folding inhibitors

Publications (1)

Publication Number Publication Date
PT1904854E true PT1904854E (pt) 2009-07-01

Family

ID=34937871

Family Applications (1)

Application Number Title Priority Date Filing Date
PT06762655T PT1904854E (pt) 2005-07-19 2006-07-17 Processo para a identificação de inibidores da dobragem de proteínas

Country Status (12)

Country Link
US (1) US20080199965A1 (pt)
EP (2) EP1746422A1 (pt)
JP (1) JP5280202B2 (pt)
CN (1) CN101228443B (pt)
AT (1) ATE426817T1 (pt)
BR (1) BRPI0613417A2 (pt)
CA (1) CA2614236A1 (pt)
DE (1) DE602006005932D1 (pt)
ES (1) ES2323654T3 (pt)
PT (1) PT1904854E (pt)
WO (1) WO2007009727A1 (pt)
ZA (1) ZA200800267B (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040435A1 (en) * 1998-02-09 1999-08-12 Netzer William J Protein folding inhibitors
WO2001034631A2 (en) * 1999-11-05 2001-05-17 Axonyx, Inc. PEPTIDE ANALOGS AND MIMETICS SUITABLE FOR IN VIVO USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL PROTEIN FOLDING INTO AMYLOID, AMYLOID-LIKE DEPOSITS OR β-SHEET RICH PATHOLOGICAL PRECURSOR THEREOF
US6689753B1 (en) * 1999-11-05 2004-02-10 Axonyx, Inc. β sheet breaker peptide analogs that inhibit β pleated sheet formation in amyloid β-peptide

Also Published As

Publication number Publication date
CN101228443A (zh) 2008-07-23
CN101228443B (zh) 2013-03-27
JP2009501535A (ja) 2009-01-22
EP1904854A1 (en) 2008-04-02
HK1115918A1 (en) 2008-12-12
EP1746422A1 (en) 2007-01-24
ZA200800267B (en) 2009-04-29
CA2614236A1 (en) 2007-01-25
DE602006005932D1 (de) 2009-05-07
WO2007009727A1 (en) 2007-01-25
JP5280202B2 (ja) 2013-09-04
ATE426817T1 (de) 2009-04-15
EP1904854B1 (en) 2009-03-25
EP1904854B9 (en) 2009-12-16
BRPI0613417A2 (pt) 2011-01-11
ES2323654T3 (es) 2009-07-22
US20080199965A1 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
MY169472A (en) Refolding of recombinant proteins
EP1869174A4 (en) LYASE ENZYMES, NUCLEIC ACIDS FOR THEIR CODING AND METHOD FOR THEIR PREPARATION AND USE
IL190796A (en) Composition containing nucleic acid encoded by anti-osteoclastogenic protein
WO2005111212A3 (en) Biological bar code
WO2010053518A3 (en) Methods and compositions for inactivating glutamine synthetase gene expression
WO2007095350A3 (en) Compositions and methods for use of pigment epithelial derived factor (pedf) peptide fragments
IL188528A0 (en) Methods and compositions for treating ophthalmic conditions via serum retinol serum retinol binding protein (rbp), and/or serum retinol-rbp modulation
WO2005111217A3 (en) Nicotiana nucleic acid molecules and uses thereof
WO2005047459A3 (en) Sars nucleic acids, proteins, antibodies, and uses thereof
WO2008094945A3 (en) Compounds and methods for modulating protein expression
ATE446314T1 (de) Methode zur reinigung von fsh
WO2010014922A3 (en) Protein purification tags and uses thereof
TNSN08471A1 (en) Methods for making and using wheat plants with increased grain protein content
UA95446C2 (ru) Мутаци в генах oas1
WO2005013904A3 (en) Sars nucleic acids, proteins, vaccines, and uses thereof
WO2007053165A3 (en) Virus protein microarray and uses therefor
WO2006047728A3 (en) Bmp gene and fusion protein
WO2007084488A3 (en) Adam10 and its uses related to infection
WO2007045019A3 (en) Polyoleosins
ZA200800267B (en) Method for the identification of proteins folding inhibitors
WO2006127822A3 (en) Scytovirin domain 1 related polypeptides
WO2006079334A3 (de) Verfahren zu nachweis und quantifizierung von proteinen unter verwendung von farbstoffen auf der basis von polymethinen
MY147959A (en) Productivity augmenting protein factor, novel cell lines and uses thereof
WO2006055040A3 (en) Identification of proteins in a genome
ATE451457T1 (de) Verfahren zur dipeptidherstellung